Author(s): Aiswarya Mohan, Aravind H, Chakravarthy S Maddipati, Roshni P R

Email(s): chakravarthy@aims.amrita.edu , sirichakri@gmail.com

DOI: 10.52711/0974-360X.2021.00957   

Address: Aiswarya Mohan1, Aravind H1, Chakravarthy S Maddipati2*, Roshni P R3**
1Doctor of Pharmacy (PharmD) Intern, Department of Pharmacy Practice, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, 682041, Kerala, India.
2MD FACP, Consultant, Department of Internal Medicine, Amrita Institute of Medical Sciences, Kochi, 682041, Kerala, India.
3Assistant Professor, Department of Pharmacy Practice, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, 682041, Kerala, India.
*Corresponding Author

Published In:   Volume - 14,      Issue - 10,     Year - 2021


ABSTRACT:
Antithyroid drugs (ATD’s) are widely used as the first line treatment option for the management of hyperthyroidism, especially for patients with Graves’ disease. They are classified into thionamide (Methimazole, Carbimazole and Propylthiouracil) and Non-thionamide (Iodine containing compounds) ATD’s. These drugs are associated with various types of adverse effects ranging from mild to potentially life threatening. Antithyroid arthritis syndome (AAS) is one of the major and uncommon side effects of ATD therapy requiring immediate drug discontinuation and hospitalization presents itself with myalgia, arthralgia and arthritis along with fever and rash of varying severity and non-specific laboratory findings, making its diagnosis and management clinically challenging. Here we report the case of 32 year old female with Graves’ disease who experienced severe migratory polyarthritis after the initiation of methimazole therapy. Her symptoms started to disappear after the prompt withdrawal of methimazole. We also concluded that this adverse effect of ATD’s might not be dose dependent by comparing our case with 6 other case reports of AAS. Here our objective is to raise awareness among the clinicians regarding the differential diagnosis and management of this major, uncommon and potentially life threatening adverse effect of ATD therapy.


Cite this article:
Aiswarya Mohan, Aravind H, Chakravarthy S Maddipati, Roshni P R. A Case Report on Methimazole Induced Anti-Thyroid Arthritis Syndrome: A Rare Drug Induced Migratory Polyarthritis. Research Journal of Pharmacy and Technology 2021; 14(10):5483-8. doi: 10.52711/0974-360X.2021.00957

Cite(Electronic):
Aiswarya Mohan, Aravind H, Chakravarthy S Maddipati, Roshni P R. A Case Report on Methimazole Induced Anti-Thyroid Arthritis Syndrome: A Rare Drug Induced Migratory Polyarthritis. Research Journal of Pharmacy and Technology 2021; 14(10):5483-8. doi: 10.52711/0974-360X.2021.00957   Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-10-75


REFERENCES:
1     Smith TJ. Hegedüs L. Graves' disease. New England Journal of Medicine. 2016 Oct 20; 375: 1552-65.
2.    Suwansaksri et al. Nonthionamide drugs for the treatment of hyperthyroidism: From present to future. International Journal of Endocrinology. 2018 Jan 1; 2018.
3.    Eliasson ME. M. Long-term prognosis after medical treatment of Graves’ disease in a northern Swedish population 2000–2010. European Journal of Endocrinology. 2014; 170: 419-27.
4.    Cooper DS. Antithyroid drugs. New England Journal of Medicine. 2005 Mar 3; 352: 905-17.
5.    Jastrzębska H. Antithyroid drugs. InThyroid research 2015 Dec 1 (Vol. 8, No. S1, p. A12). Bio Med Central.
6.    Liu et al. Antithyroid drug therapy for Graves’ disease and implications for recurrence. International Journal of Endocrinology. 2017 Apr 25; 2017.
7.    Shabtai et al. The antithyroid arthritis syndrome reviewed. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 1984 Feb;27: 227-9.
8.    Mancuso et al. Colchicine as a new therapeutic option for antithyroid arthritis syndrome. Rheumatology. 2020 Jun 1; 59: 1452-3.
9.    Khaledi et al. Arthritis Associated With Low Dose Methimazole Therapy: A Case Report. Iranian Journal of Pharmaceutical Sciences. 2018 Dec; 14: 55-62.
10.    Modi et al. Antithyroid arthritis syndrome. Case Reports. 2017 Feb 27;2017:bcr2016218459.
11.    Shikha et al. Antineutrophilic cytoplasmic antibody positive vasculitis associated with methimazole use. Case Reports in Endocrinology. 2015 Apr 28; 2015.
12.    Pearce EN. Diagnosis and management of thyrotoxicosis. Bmj. 2006 Jun 8; 332: 1369.
13.    Cooper DS. The side effects of antithyroid drugs. The Endocrinologist. 1999 Nov 1; 9: 457-78.
14.    Ahamed et al. Insulin autoimmune syndrome (Hirata disease) associated with carbimazole therapy. Thyroid Research and Practice. 2010 Jan 1; 7: 22
15.    Williams et al. Thiouracil Treatment of Thyrotoxicosis: II. Toxic Reactions. The Journal of Clinical Endocrinology. 1946 Jan 1; 6: 23-51
16.    Ploegstra et al. Arthritis associated with antithyroid therapy in a 15-year-old girl. The Journal of Pediatric Pharmacology and Therapeutics. 2011; 16: 98-101.
17.    Nikitopoulou E, Gazi S. Antithyroid drug induced syndrome that lies in between ANCA vasculitis and lupus like syndrome in a 40-year-old female with Graves’ disease under methimazole therapy: A Case report. Mediterranean Journal of Rheumatology. 2018; 29.
18.    Karch FE, Lasagna L. Adverse drug reactions: a critical review. Jama. 1975 Dec 22;234: 1236-41.
19.    Nihei et al. Polyarthritis caused by methimazole in two Japanese patients with Graves’ disease. Journal of Clinical Research in Pediatric Endocrinology. 2013 Dec;5: 270.
20.    Takaya et al. Antithyroid arthritis syndrome: A case report and review of the literature. Internal Medicine. 2016 Dec 15; 55: 3627-33.
21.    Cooper DS. Antithyroid drugs in the management of patients with Graves’ disease: an evidence-based approach to therapeutic controversies. The Journal of Clinical Endocrinology & Metabolism. 2003 Aug 1; 88: 3474-81.
22.    Nakamura et al. Working Group of the Japan Thyroid Association for the Guideline of the Treatment of Graves’ Disease. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves’ disease. The Journal of Clinical Endocrinology and Metabolism. 2007 Jun 1; 92: 2157-62.
23.    Schatz SN, Weber RJ. Adverse drug reactions. ACCP (American College of Clinical Pharmacy). CNS. Pharmacy Practice, PSAP. 2015.
24.    Naranjo et al. A method for estimating the probability of adverse drug reactions. Clinical Pharmacology and Therapeutics. 1981 Aug; 30: 239-45

Recomonded Articles:

Author(s): Manju Rawat, SJ Daharwal, Deependra Singh

DOI:         Access: Open Access Read More

Author(s): Shyama S. Kumar, Divya Bhosle, Akshay Janghel, Shraddha Deo, Parijeeta Raut, Chetan Verma, Mukta Agrawal, Nisha Amit, Mukesh Sharma, Tapan Giri, D. K. Tripathi1, Ajazuddin, Amit Alexander

DOI: 10.5958/0974-360X.2015.00099.2         Access: Open Access Read More

Author(s): A. Rajendra Kumar, N. J. Muthukumar, A. Faridha

DOI: 10.5958/0974-360X.2019.00081.7         Access: Open Access Read More

Author(s): V. Swathi, G. Velrajan, Balasubramaniam

DOI: Not Available         Access: Open Access Read More

Author(s): Rupesh Pandey, Priyanka Upadhayay, Shiv Shankar Shukla

DOI:         Access: Open Access Read More

Author(s): Aniruddh Menon, M.S.Thenmozhi

DOI: 10.5958/0974-360X.2016.00307.3         Access: Open Access Read More

Author(s): Krithika. R. Iyengar, M. Komala, S. Satheeshkumar

DOI: 10.5958/0974-360X.2020.01089.6         Access: Open Access Read More

Author(s): Hindustan Abdul Ahad, Chinthaginjala Haranath, Srikantham Sai Vikas, Naga Jyothi Varam, Tarun Ksheerasagare, Surya Prakash Reddy Gorantla

DOI: 10.5958/0974-360X.2021.00094.9         Access: Open Access Read More

Author(s): P. Maheshwari, Rani Mohan, T. S. Shanmugarajan

DOI: 10.5958/0974-360X.2017.00010.5         Access: Open Access Read More

Author(s): Suman Katteboina and VSR Chandrasekhar P

DOI: Not Available         Access: Open Access Read More

Author(s): Anamika Gautam, Harmeet Kaur, Arvinder Kaur, Pankaj Kumar Prashar, Ankita Sood, Sachin Kumar Singh, Monica Gulati, Narendra Kumar Pandey, Bimlesh Kumar

DOI: 10.5958/0974-360X.2020.00980.4         Access: Open Access Read More

Author(s): Neveda Baskeran

DOI: Not Available         Access: Open Access Read More

Author(s): Krishna Ravi, Rosmi Jose, Sumitha SK, Teena Johny, Krishnaveni K, Shanmuga Sundaram R, Sambath Kumar R

DOI: 10.5958/0974-360X.2017.00490.5         Access: Open Access Read More

Author(s): Rinky Thakur, Ajay Kumar Meena, Amit Kumar Dixit, Suma Joshi

DOI: 10.5958/0974-360X.2018.00766.7         Access: Open Access Read More

Author(s): Katolkar P Parimal, Hirulkar R Mayuresh, Baheti R Jagdish, Meshram S Satish

DOI: 10.5958/0974-360X.2020.00884.7         Access: Open Access Read More

Author(s): Srishti Chaudhary, Pankaj Kumar Prashar, Anamika Gautam, Ankita Sood, Sachin Kumar Singh, Monica Gulati, Narendra Kumar Pandey, Bimlesh Kumar

DOI: 10.52711/0974-360X.2021.00507         Access: Closed Access Read More

Author(s): S. Subasree

DOI: Not Available         Access: Open Access Read More

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags